Enhanced Valves Interventions and Safe AI Generated End Results

NCT07213531 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 21000

Last updated 2025-10-09

No results posted yet for this study

Summary

This non-interventional study aims to use artificial intelligence to improve the prediction of transcatheter heart valve interventions and optimize patient outcomes. It is based on the analysis of retrospective data from various specialized centers worldwide.

Conditions

  • Heart Valve Disease
  • TAVI
  • M-TEER
  • TTVI
  • TMVI
  • T-TEER
  • Mitraclip
  • TriClip

Interventions

DIAGNOSTIC_TEST

Medical imaging analysis via artificial intelligence algorithms

Development of AI algorithms based on pre-procedural imaging annotations and clinical informations to predict the transcatheter procedural outcomes

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Bordeaux, FRANCE

    collaborator UNKNOWN
  • Materialise

    collaborator INDUSTRY
  • Pie Medical Imaging

    collaborator UNKNOWN
  • Clinique Pasteur Toulouse

    collaborator OTHER
  • Centre Cardiologique du Nord

    collaborator OTHER
  • CHU Rennes,France

    collaborator UNKNOWN
  • San Raffaele University Hospital, Italy

    collaborator OTHER
  • Istituto clinico Città di Brescia

    collaborator UNKNOWN
  • Unity Health Toronto

    collaborator OTHER
  • University Hospital, Marseille

    collaborator OTHER
  • Lille University Hospital

    collaborator UNKNOWN
  • Hospitaux Universitaires Paris Sud

    collaborator UNKNOWN
  • Montefiore Medical Center

    collaborator OTHER
  • University Medical Center Mainz

    collaborator OTHER
  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER
  • Vancouver Hospital

    collaborator UNKNOWN
  • Montreal Heart Institute

    lead OTHER

Principal Investigators

  • Thomas Modine, MD, PhD · University Hospital Bordeaux, France

  • Walid Ben Ali, MD, PhD · Montreal Heart Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2028-05-31
Completion
2029-05-31

Countries

  • United States
  • Canada
  • France
  • Germany
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07213531 on ClinicalTrials.gov